What were Bombay Super Hybrid Seeds Ltd's latest quarterly results?
Bombay Super Hybrid Seeds Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -14.0%
- Revenue Growth YoY: -15.9%
- Operating Margin: 8.9%
Bombay Super Hybrid Seeds Ltd (Seeds/Tissue Culture/Bio Technology) — fundamental analysis, earnings data, and key metrics. PE: 26.7. ROE: 28.8%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Bombay Super Hybrid Seeds Ltd's latest quarterly results (Dec 2025) show
Bombay Super Hybrid Seeds Ltd's current PE ratio is 26.7x.
Bombay Super Hybrid Seeds Ltd's price-to-book ratio is 5.9x.
Bombay Super Hybrid Seeds Ltd's fundamental strength based on key financial ratios
Bombay Super Hybrid Seeds Ltd has a debt-to-equity ratio of N/A.
Bombay Super Hybrid Seeds Ltd's return ratios over recent years
Bombay Super Hybrid Seeds Ltd's operating cash flow is negative (FY2025).
Bombay Super Hybrid Seeds Ltd currently does not pay a significant dividend (yield 0.00%).
Bombay Super Hybrid Seeds Ltd's shareholding pattern (Dec 2025)
Bombay Super Hybrid Seeds Ltd's promoter holding has remained stable recently.
Bombay Super Hybrid Seeds Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Bombay Super Hybrid Seeds Ltd may be worth studying
Bombay Super Hybrid Seeds Ltd investment thesis summary:
Bombay Super Hybrid Seeds Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.